GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Qurient Co Ltd (XKRX:115180) » Definitions » Net Margin %

Qurient Co (XKRX:115180) Net Margin % : -245.68% (As of Mar. 2024)


View and export this data going back to 2016. Start your Free Trial

What is Qurient Co Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. Qurient Co's Net Income for the three months ended in Mar. 2024 was ₩-5,190 Mil. Qurient Co's Revenue for the three months ended in Mar. 2024 was ₩2,113 Mil. Therefore, Qurient Co's net margin for the quarter that ended in Mar. 2024 was -245.68%.

The historical rank and industry rank for Qurient Co's Net Margin % or its related term are showing as below:

XKRX:115180' s Net Margin % Range Over the Past 10 Years
Min: -4973.15   Med: -384.12   Max: -220.55
Current: -220.55


XKRX:115180's Net Margin % is ranked worse than
54.72% of 1018 companies
in the Biotechnology industry
Industry Median: -148.36 vs XKRX:115180: -220.55

Qurient Co Net Margin % Historical Data

The historical data trend for Qurient Co's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Qurient Co Net Margin % Chart

Qurient Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Net Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - -467.63 -300.61 -233.80

Qurient Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -300.90 -259.98 -207.31 -174.20 -245.68

Competitive Comparison of Qurient Co's Net Margin %

For the Biotechnology subindustry, Qurient Co's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Qurient Co's Net Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Qurient Co's Net Margin % distribution charts can be found below:

* The bar in red indicates where Qurient Co's Net Margin % falls into.



Qurient Co Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Qurient Co's Net Margin for the fiscal year that ended in Dec. 2023 is calculated as

Net Margin=Net Income (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=-21116.659/9031.807
=-233.80 %

Qurient Co's Net Margin for the quarter that ended in Mar. 2024 is calculated as

Net Margin=Net Income (Q: Mar. 2024 )/Revenue (Q: Mar. 2024 )
=-5190.226/2112.607
=-245.68 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Qurient Co  (XKRX:115180) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


Qurient Co Net Margin % Related Terms

Thank you for viewing the detailed overview of Qurient Co's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Qurient Co (XKRX:115180) Business Description

Traded in Other Exchanges
N/A
Address
C-dong 8th Floor, 242, Pangyo-ro, Bundang-gu, Seongnam-si, Gyeonggi-do, KOR, 13487
Qurient Co Ltd is a South Korea based biotech company. It is engaged in network research & development business model, integrating research and drug development programs with a new mechanism. Its pipeline products include Q301 for the treatment of atopic dermatitis; Q203 treats MDR/XDR/TDR TB, and Q701 is a drug-resistant cancer immuno-oncology.

Qurient Co (XKRX:115180) Headlines

No Headlines